Sort
17,288 grants matching “multiple sclerosis”
Ibudilast Phase II trial in progressive MS
$3,102,097Robert J. Fox · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · NS
General Clinical Research Center
$3,084,022Paul B Roth · University Of New Mexico · M01 · FY2006 · RR
Health Disparities Research at UCR
$3,077,391David D Lo · University Of California Riverside · U54 · FY2022 · MD
From therapeutic mechanisms to unraveling the pathophysiology of MS
$3,010,433Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Health Disparities Research at UCR
$3,009,642David D Lo · University Of California Riverside · U54 · FY2023 · MD
NICHD RADX TECH ACT ENDO CHALLENGE AWARD - INITIAL OBLIGATION
$3,000,000 · N01 · FY2024 · HD
Development of a Novel Bi-Specific Antibody Based Therapeutic that Simultaneously
$2,999,972Paul Andrew Moore · Macrogenics, Inc. · RC3 · FY2010 · AI
Risk Factors, Pathology, and Clinical Expressions of AD
$2,950,095David A Bennett · Rush University Medical Center · R01 · FY2022 · AG
Mitotic roles of the Nuclear Transport Machinery
$2,935,078Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
NRT-UtB: Neurophotonics
$2,928,842Thomas G Bifano · Trustees Of Boston University · · FY2016 · EDU
Clinical and biomarker studies in Alzheimer's disease and related disorders
$2,919,364Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2021 · AG
Single cell RNA-seq analyses of age-related changes in glial cells and in AD
$2,885,990Junying Yuan · Harvard Medical School · RF1 · FY2017 · AG
Risk Factors, Pathology, and Clinical Expressions of AD
$2,884,209David A Bennett · Rush University Medical Center · R01 · FY2021 · AG
Stat transcription factors in immunoregulation and autoimmune disease
$2,873,883John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
Risk Factors, Pathology, and Clinical Expressions of AD
$2,868,751David A Bennett · Rush University Medical Center · R01 · FY2024 · AG
Epigenetic regulation through the formation and resolution of R loops
$2,850,000Kavitha Sarma · Wistar Institute · DP2 · FY2017 · NS
Sphingosine-1-phosphate induced modulation of inflammation in aging and Alzheimer's disease
$2,830,766Alpaslan Dedeoglu · Boston University Medical Campus · RF1 · FY2017 · AG
Ibudilast Phase II trial in progressive MS
$2,827,318Robert J. Fox · Cleveland Clinic Lerner Com-Cwru · U01 · FY2015 · NS
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics with Multiple Sclerosis
$2,825,047Stephanie Silveira Gee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · MD
The role of a metazoan-specific PQC system in protecting against TDP-43 proteinopathies
$2,817,215Xiaolu Yang · University Of Pennsylvania · RF1 · FY2025 · NS
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$2,805,110Claudia H. Kawas · University Of California-Irvine · R01 · FY2019 · AG
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$2,804,788Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Mechanisms of inherited neurodegenerative diseases
$2,762,771Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Mechanisms of inherited neurodegenerative diseases
$2,735,178Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
A Haplotype Map for Multiple Sclerosis
$2,717,681University Of California San Francisco · R01 · FY2005 · NS